Skip to main content
padlock icon - secure page this page is secure

NeoSeal to Prevent Nasal Injury in Preterm Infants Receiving Oxygen Therapy

Buy Article:

$17.00 + tax (Refund Policy)

Purpose: To determine if a foam septum protector prevents nasal injury in preterm infants receiving nasal heated humidified oxygen.

Design: A retrospective before and after comparative design was used.

Sample: Medical records of 101 preterm infants receiving either nasal continuous positive airway pressure (NCPAP) or nasal intermittent positive pressure ventilation (NIPPV) were reviewed; 50 were in the control group and 51 were in the intervention group that had the NeoSeal septum protector applied. The groups were not different in terms of gender, birth weight, gestational age, days intubated, or on days on NCPAP/NIPPV. Skin condition of nares was scored daily using the Neonatal Skin Risk Assessment Scale (NSRAS).

Results: Infants who had the NeoSeal applied had significantly less nasal injuries, OR = 4.08; 95% confidence interval (CI), 1.22–9.59; p = .01. The best predictors of nasal injury were gestational age and whether the NeoSeal was applied or not.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE (NCPAP); NASAL/COLUMELLA NECROSIS

Document Type: Research Article

Affiliations: Azusa Pacific University, 700 E. Foothill Ave., Azusa, CA 91701, USA

Publication date: July 1, 2016

More about this publication?
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more